(2-amino-5-bromo-phenyl)-(4-fluoro-phenyl)methanone | 395101-26-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (2-amino-5-bromo-phenyl)-(4-fluoro-phenyl)methanone
• 英文别名: (2-amino-5-bromophenyl)(4-fluorophenyl)methanone；2-amino-5-bromo-4′-fluorobenzophenone；(2-Amino-5-bromo-phenyl)-(4-fluoro-phenyl)-methanone；2-Amino-5-bromo-4'-fluorobenzophenone；(2-amino-5-bromophenyl)-(4-fluorophenyl)methanone
• CAS: 395101-26-5
• 化学式: C₁₃H₉BrFNO
• 分子量: 294.123
• InChiKey: WZXFXBLNORUZFU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  43.1
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (2-amino-5-bromo-phenyl)-(4-fluoro-phenyl)methanone 在 吡啶 、 titanium(III) chloride 、 锌 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 5.5h， 生成 5-bromo-3-(4-fluorophenyl)-2-pyridin-4-yl-1H-indole
  参考文献：
  名称：

  Design and Synthesis of 4-Azaindoles as Inhibitors of p38 MAP Kinase

  摘要：

  Inhibition of the biosynthesis of proinflammatory cytokines such as tumor necrosis factor and interleukin-1 via p38 has been an approach toward the development of a disease modifying agent for the treatment of chronic inflammation and autoimmune diseases. The development of a new core structure of p38 inhibitors, 3-(4-fluorophenyl)-2-(pyridin-4-yl)-1H-pyrrolo[3,2-b] pyridine, is described. X-ray crystallographic data of the lead bound to the active site of p38 was used to guide the optimization of the series. Specific focus was placed on modulating the physical properties of the core while maintaining potent inhibition of p38. These efforts identified 42c as a potent inhibitor of p38, which also possessed the required physical properties worthy of advanced studies.

  DOI：

  10.1021/jm0301787
• 作为产物：
  描述：

  2-amino-5-bromobenzoic acid hydrochloride 在 N-甲基吗啉 、 正丁基锂 、 O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 作用下， 以 四氢呋喃 、 正己烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 1.0h， 生成 (2-amino-5-bromo-phenyl)-(4-fluoro-phenyl)methanone
  参考文献：
  名称：

  氟溴西epa位置异构体的合成用于法医分析。

  摘要：

  最近，在许多法医案件中，设计师苯二氮卓类药物已作为联邦定点药物的合法替代品出现，如地西epa（Valium）和阿普唑仑（Xanax）。尽管当前的取证工具技术通常足以识别新型精神活性物质，但它们可能不容易区分潜在的位置异构体。另外，已知设计者苯并二氮杂s的位置异构体的表征数据广泛不存在。在这项研究中，氟溴马西m是自2012年以来公认的苯并二氮杂designer设计者，由于其有可能在美国进行联邦检定和目前的法律地位，因此被用于合成和表征。开发了一种实用的合成方法，以制备氟溴西m的每个位置异构体的纯化参考物质，其中溴和氟取代基的位置不同。成功制备了可能的异构体（12种中的9种），并用于进一步分析。

  DOI：

  10.1021/acs.joc.9b01433

文献信息

• Methods for treating an inflammatory condition or inhibiting JNK
  申请人：——

  公开号：US20040127536A1

  公开（公告）日：2004-07-01

  This invention is generally directed to Indazole Derivatives having the following structure: 1 or pharmaceutically acceptable salt thereof, wherein R 1 , R 2 and A are as defined herein. Such compounds have utility in the treatment of a wide range of diseases and disorders that are responsive to JNK inhibition, such as an inflammatory disease or disorder. Thus, methods of treating such diseases and disorders are also disclosed, as are pharmaceutical compositions containing one or more compounds of the above compounds.

  这项发明通常涉及吲唑衍生物，具有以下结构： 1 或药用可接受的盐，其中R 1 ，R 2 和A如本文所述定义。这类化合物在治疗对JNK抑制剂有响应的广泛疾病和障碍，如炎症性疾病或障碍中具有用途。因此，还披露了治疗这些疾病和障碍的方法，以及包含一个或多个上述化合物的药物组合物。
• Indazole compounds, compositions thereof and methods of treatment therewith
  申请人：Bhagwat S. Shripad

  公开号：US20050009876A1

  公开（公告）日：2005-01-13

  This invention is generally directed to the use of Indazole Compounds for treating or preventing diseases associated with protein kinases, including tyrosine kinases, such as proliferative diseases, inflammatory diseases, abnormal angiogenesis and diseases related thereto, atherosclerosis, macular degeneration, diabetes, obesity, pain and others. The methods comprise the administration to a patient in need thereof of an effective amount of an indazole compound that inhibits, modulates or regulates tyrosine kinase signal transduction. Novel indazole compounds or pharmaceutically acceptable salt thereof are presented herein.

  这项发明通常涉及使用吲唑化合物来治疗或预防与蛋白激酶相关的疾病，包括酪氨酸激酶，诸如增殖性疾病、炎症性疾病、异常血管生成及其相关疾病、动脉硬化、黄斑变性、糖尿病、肥胖、疼痛等。这些方法包括向有需要的患者施用有效量的吲唑化合物，以抑制、调节或控制酪氨酸激酶信号转导。本文中提供了一种新型的吲唑化合物或其药用可接受的盐。
• Indazole derivatives as JNK inhibitors and compositions and methods related thereto
  申请人：——

  公开号：US20020103229A1

  公开（公告）日：2002-08-01

  Compounds having activity as selective inhibitors of JNK are disclosed. The compounds of this invention are indazole derivatives having the following structure: 1 wherein R 1 , R 2 and A are as defined herein. Such compounds have utility in the treatment of a wide range of conditions that are responsive to JNK inhibition. Thus, methods of treating such conditions are also disclosed, as are pharmaceutical compositions containing one or more compounds of the above compounds.

  本发明公开了作为JNK选择性抑制剂的化合物。本发明的化合物是吲唑衍生物，具有以下结构： 1 其中R 1 ，R 2 和A如本文所述定义。此类化合物在治疗对JNK抑制产生响应的广泛病症方面具有用途。因此，还公开了治疗此类病症的方法，以及包含一个或多个上述化合物的药物组合物。
• New vistas in quinoline synthesis
  作者：Sarkis Atechian、Nadine Nock、Roger D. Norcross、Hassen Ratni、Andrew W. Thomas、Julien Verron、Raffaello Masciadri

  DOI：10.1016/j.tet.2007.01.050

  日期：2007.3

  The gold-catalyzed Friedlander reaction was applied to the condensation of 2-aminoarylketones with β-keto-esters, β-diketones, β-keto-amides, and β-keto-sulfones to afford a diverse range of 2,3,4-trisubstituted quinolines in 3–82% yield. The seven-membered rings 1,3-cycloheptadione and azepane-2,4-dione reacted smoothly in 75% yield. An alternative procedure for the synthesis of 3-(methanesulfonyl)quinolines

  金催化的弗里德兰德反应用于2-氨基芳基酮与β-酮酯，β-二酮，β-酮酰胺和β-酮砜的缩合反应，从而得到范围广泛的2,3,4-三取代喹啉，产率3–82％。七元环1,3-环庚二酮和氮杂环庚烷-2,4-二酮反应平稳，产率为75％。开发了另一种合成3-（甲磺酰基）喹啉的方法，并为进入后期操作这些喹啉的4-位开辟了道路。Friedlander反应所需的2-氨基芳基酮是在一锅中通过改良的Sugasawa反应使用氯化镓（III）和氯化硼（III）制备的，产率为12-54％。
• Synthesis of Indoles from 2-Vinylanilines with PIFA or TFA and Quinones
  作者：Rulong Yan、Mingzhong Wu

  DOI：10.1055/s-0036-1588122

  日期：——

  The cyclizations involved in the synthesis of different indoles from 2-vinylanilines with PIFA [bis(trifluoroacetoxy)iodo]benzene} and quinones have been developed under mild conditions. Various substituents on 2-vinylanilines induced good compatibility and gave the desired products in moderate to good yields.

  从 2-乙烯基苯胺与 PIFA [双（三氟乙酰氧基）碘]苯}和醌类合成不同吲哚所涉及的环化反应是在温和条件下开发的。2-乙烯基苯胺上的各种取代基具有良好的相容性，并以中等至良好的产率得到所需的产物。